Find public sector tenders

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (cover ....

NHS National framework agreement for the supply of aseptically prepared cytotoxic medicines and monoclonal antibodies – North of England. Period of framework agreement: 1 April 2021 to 31 March 2022 with an option or options to extend (at the Autho ....

National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies - North of England

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to ....

NHS framework agreement to supply aseptically prepared cytotoxic medicines and monoclonal antibodies — East of England, London and South East Coast. The framework may also be used by private sector contractors and agents working on behalf of the ab ....

NHS framework agreement to supply the North of England - Dose Banded Cytotoxic Medicines. The framework will commence on 1st December 2016 for a period of 2 years until 30th November 2018, with options to extend for up to a further 24 months. Please ....

NHS framework agreement to supply the North of England — Dose Banded Cytotoxic Medicines. The framework will commence on 01.12.2016 for a period of 2 years until 30.11.2018, with options to extend for up to a further 24 months.Please refer to the I ....

Dose Banded Cytotoxic Chemotherapy Medicines – Framework to supply the London Cancer Alliance and London Cancer.

NHS Framework agreement for the supply of Dose Banded Cytotoxic Medicines to the East of England. Please refer to the ITO documents, Document No. 04 for the list of Participating Authorities. The agreement will start on 1.11.2014 to 31.10.2016 with o ....

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (coveri ....